NMDA receptor hypofunction model of schizophrenia

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

Excitatory Amino Acid Transmitters

Watkins, J. C., & Evans, R. H. (1981) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,497

Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain

Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793

Glutamate receptor dysfunction and schizophrenia

Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685

Ketamine—its pharmacology and therapeutic uses

white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474

Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs

Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,230

Study of a New Schizophrenomimetic Drug—Sernyl

LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921

Trans-generation enrichment of clozapine-responsiveness trait in mice using a subchronic hypo-glutamatergic model of schizophrenia:A preliminary study

Krivoy, A., Gil‐Ad, I., Tarasenko, I., Weizman, A., & Taler, M. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.044 · Cited by 3

Anti-NMDA-Rezeptor-Enzephalitis: Ein interdisziplinäres Krankheitsbild

Prüß, H., Dalmau, J. O., Arolt, V., & Wandinger, K.-P. (2010) · Der Nervenarzt · Cited by 3

Schizophrenia, Oxidative Stress and Selenium

Pitts, M. W., Raman, A. V., & Berry, M. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1025-6_28 · Cited by 3

Cortical connectivity in high-frequency beta-rhythm in schizophrenics with positive and negative symptoms

Стрелец, В. Б. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03440028 · Cited by 3

Contributions of Traumatic Stress Studies to the Neurobiology of Dissociation and Dissociative Disorders: Implications for Schizophrenia

Vermetten, E. H. G. J. M., Lanius, R. A., & Bremner, J. D. (2008) · Wiley eBooks · doi:10.1002/9780470699652.ch16 · Cited by 3

State-dependent alteration of dopamine and glutamate transmission in the prefrontal cortex by psychostimulants

Tanaka, S. (2004) · Neurocomputing · doi:10.1016/j.neucom.2004.10.048 · Cited by 3

Effect of amphetamine and phencyclidine on DNA-binding activities of serum response and dyad symmetry elements

Milanović, D., Milošević, J., Kanazir, S., Rakić, L., & Ruždijić, S. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00133-x · Cited by 3

D-serine supplement ameliorates MPP+-induced neurotoxicity via attenuating DAPK1-associated pathway in Parkinson's disease modelsPreprint

Zhang, W., Sun, X., Liu, J., Peng, Y., Qin, Y., Xu, Y., Zhang, H.-L., Ding, W., Li, S., & Ma, L. (2021) · Research Square · doi:10.21203/rs.3.rs-892540/v1 · Cited by 3

Enriched environment prevented glutamate receptor loss in the prefrontal cortex to alleviate CUMS-induced depression-like behaviors

Xu, Y., Du, J., Du, Z.-A., Liu, D.-L., Chen, K., Che, Y., Wu, F., Yu, G., Zhang, W.-B., Zheng, X., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120634 · Cited by 2

Acute Phencyclidine Alters Neural Oscillations Evoked by Tones in the Auditory Cortex of Rats

Martin, A. M. S., O’Donnell, B. F., Millward, J. B., Vohs, J. L., Leishman, E., Bolbecker, A. R., Rass, O., & Morzorati, S. L. (2017) · Neuropsychobiology · doi:10.1159/000480511 · Cited by 2

Neural processing in the primary auditory cortex following cholinergic lesions of the basal forebrain in ferrets

Nodal, F. R., Leach, N. D., Keating, P., Dahmen, J. C., Zhao, D., King, A. J., & Bajo, V. M. (2024) · Hearing Research · doi:10.1016/j.heares.2024.109025 · Cited by 3

Effects of Sarcosine (N-methylglycine) on NMDA (N-methyl-D-aspartate) Receptor Hypofunction Induced by MK801: In Vivo Calcium Imaging in the CA1 Region of the Dorsal Hippocampus

Hsiao, Y., Chang, C., Lee, T.-Y., Liao, W.-T., Lai, W., & Chang, F. (2024) · Brain Sciences · doi:10.3390/brainsci14111150 · Cited by 2

How Layer-Specific fMRI Can Contribute to Understanding Perceptual Disturbances Across Psychiatric Disorders

Haarsma, J., & Kok, P. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_595 · Cited by 2

Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice

Shen, A. N., & Newland, M. C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4120-x · Cited by 2

Neurophysiological analysis of schizophrenia based on dysfunction of the glutamatergic system using a tripartite synapse model

Mahdavi, A., Bahrami, F., & Janahmadi, M. (2013) · National and International Iranian Conference on Biomedical Engineering (ICBME) · doi:10.1109/icbme.2013.6782215 · Cited by 2

The journal of psychiatric research celebrates its 50th anniversary in 2011

Schatzberg, A. F., & Holsboer, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.12.001 · Cited by 2

Glutamatergic Neurotransmission Abnormalities and Schizophrenia

Dwivedi, Y., & Pandey, G. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_13 · Cited by 2

Phenomenology, context, and self-experience in schizophrenia

Sass, L. A., & Uhlhaas, P. J. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03430021 · Cited by 2

Development of legal highs

Wasunna, B., Thomas, E., & Morgan, S. (2015) · Journal of Psychiatric Intensive Care · doi:10.1017/s1742646415000011 · Cited by 2

Clinical Effects and Applications of Ketamine

Roback, M. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-47609-4_14 · Cited by 2

Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia

Thomson, S., Dyck, B. A., Daya, R. P., Ho, J., Bernardo, A. M., Tian, Y., & Mishra, R. K. (2018) · Synapse · doi:10.1002/syn.22084 · Cited by 2

Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues

Ho, J. H., & Dargan, P. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-20790-2_124-2 · Cited by 2

Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022)

Reilly, T. J. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15872 · Cited by 1

Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)

Sánchez-Florentino, Z. A., Romero-Martínez, B. S., Flores‐Soto, E., Serrano, H., Montaño, L., Valdés‐Tovar, M., Calixto, E., Aquino‐Gálvez, A., López-Riquelme, G. O., Alvarado, R., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5331 · Cited by 2

Enhanced locomotor stimulation by NMDA receptor antagonists in alcohol-sensitive ANT rats

Vekovischeva, O. Y., Haapalinna, A., Näkki, R., Sarviharju, M., Honkanen, A., Heikkilä, J., & Korpi, E. R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00424-x · Cited by 2

Modeling the schizophrenias: subunit-specific NMDAR antagonism dissociates frontal δ and hippocampal θ modulation of ~140 Hz oscillationsPreprint

Pittman-Polletta, B., Hu, K., & Kocsis, B. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/191882 · Cited by 2

Neuro-behavioral effects after systemic administration of MK-801 and disinhibition of the anterior thalamic nucleus in rats: Potential relevance in schizophrenia

López‐Hill, X., Richeri, A., McGregor, R., Acuña, A., & Scorza, C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.005 · Cited by 1

Attenuated Psychosis Syndromes Among Mexican Youth and Young Adults: A Culturally Relevant Case Illustration Approach

Reyes-Madrigal, F., León-Ortíz, P., & de la Fuente‐Sandoval, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-17336-4_13 · Cited by 1

NMDA receptor antagonist induced c-Fos expression in the medial entorhinal cortex during postnatal development

Liang, F., Wang, H., & Naumann, R. K. (2025) · Frontiers in Neural Circuits · doi:10.3389/fncir.2025.1619534 · Cited by 2

GluN2A-NMDA receptor inhibition disinhibits the prefrontal cortex, reduces forced swim immobility, and impairs sensorimotor gating

Dong, Y., Wu, Y., Zhao, Y.-L., Chen, Y.-M., Liu, T.-Y., Zhang, Y.-H., Xie, J.-Y., Zhang, J., Zhang, H., Chen, H., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01643-2 · Cited by 1

Augmentation with glutamatergic modulators for schizophrenia: A network meta-analysis

Liang, C.-W., Cheng, H.-Y., & Tseng, M. M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111495 · Cited by 3

Corticosterone-linked microglial activity underpins sexually dimorphic neuroplasticity after ketamine anesthesia

Venturino, A., Alamalhoda, M., Negrello, T., Jin, K., van Velthoven, C. T. J., Cubero, R. J., Yeung, J., Koppensteiner, P., Tasic, B., & Siegert, S. (2026) · Science Advances · doi:10.1126/sciadv.adz6517 · Cited by 1

Serum levels of S100B in patients with chronic schizophrenia during treatment augmentation with sarcosine: results of the double-blind, randomized, placebo-controlled PULSAR study

Pawlak, A., Wysokiński, A., & Strzelecki, D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1705310 · Cited by 1

The thalamic nucleus reuniens orchestrates prefrontal-hippocampal synchrony in memory, emotion, and disease

Tuna, T., & Maren, S. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1885971 · Cited by 1

Effect of phencyclidine derivatives on anxiety-like behavior using an elevated-plus maze test in mice.

Hajikhani, R., Ahmadi, A., Naderi, N., Yaghoobi, K., Shirazi-zand, Z., Rezaee, N. M., & Niknafs, B. N. (2012) · PubMed · Cited by 1

In vitro binding of a radio‐labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5

Zysk, J. R., Spear, N., Fieles, W. E., Stein, M. M., Sygowski, L. S., King, M. M., Hoesch, V., Hastings, R., Brockel, B. J., Do, M., et al. (2012) · Synapse · doi:10.1002/syn.21625 · Cited by 1

Sincronía neuronal y esquizofrenia: luces y sombras

Niklitschek, S., Paula Pino, P., & Aboitiz, F. (2011) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272011000400009 · Cited by 1

Linking brain to mind in normal behavior and schizophrenia

Grossberg, S. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03300020 · Cited by 1

Paliperidone in the treatment of Schizophrenia: An overview

Capasso, A., & Milano, W. (2012) · Current Neurobiology · Cited by 2

THE TREATMENT OF THE SCHIZOPHRENIA: AN OVERVIEW

Galizia, G. (2009) · Cited by 1

Site of Ketamine Action on the NMDA Receptor

Mori, H. (2020) · Springer eBooks · doi:10.1007/978-981-15-2902-3_4 · Cited by 1

Ketamine

Li, Q., Chan, W. M., Rudd, J. A., Wang, C. M., Lam, P. Y. H., Wai, M. S. M., Wood, D. M., Dargan, P. I., & Yew, D. T. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00012-2 · Cited by 1

Magnetic Resonance Spectroscopy

Milev, P., Miranowski, S., & Lim, K. O. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_13 · Cited by 1

D2 receptor activation modulates NMDA receptor antagonist-enhanced high-frequency oscillations in the olfactory bulb of freely moving rats

Wróbel, J., Wojcik, D. K., & Hunt, M. J. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06808-9 · Cited by 1

Mismatch Negativity in Subjects at Clinical High Risk for Psychosis: No Evidence of Progressive Decline

Jang, J., Choe, E., Ha, M., Kim, M., & Kwon, J. S. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70256 · Cited by 1

Clozapine Combinations in Treatment-Resistant Schizophrenia Patients

Lerner, V., & Miodownik, C. (2012) · Springer eBooks · doi:10.1007/978-94-007-5799-8_7 · Cited by 1

Inhibition of Glycine Transporter-1 Improves the Functional Outcome of Schizophrenia

Hui, C., & Tsai, G. E. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_19 · Cited by 1

Combating fuzziness with computational modeling

Talamini, L. M., Meeter, M., & Murre, J. M. J. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03460020 · Cited by 1

Neurometabolic Profiling of Ketamine

Napolitano, A., & Andellini, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00053-4 · Cited by 1

Arylcyclohexamines

Salter, M. D., & Gunja, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818788-3.00011-5 · Cited by 1

6-Hydroxydopamine Lesioning of Dopamine Neurons in Neonatal and Adult Rats Induces Age-Dependent Consequences

Papadeas, S. T., & Breese, G. R. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_59 · Cited by 2

Zmiana parametrów elektrookulograficznych u chorych na schizofrenię leczonych glicyną. Wyniki prospektywnego badania otwartego

Strzelecki, D., & Rabe‐Jabłońska, J. (2009) · Psychiatria i Psychologia Kliniczna · Cited by 1

The Contribution of System Xc-to Prefrontal Cortical Mediated Behaviors Associated with Schizophrenia

Lutgen, V. (2012) · e-Publications@Marquette (Marquette University) · Cited by 1

Cognition and social behaviour in schizophrenia: An animal model investigating the potential role of nitric oxide

Wass, C. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1

Influenza A virus infection and NMDA receptor function : A behavioral and molecular study of relevance for schizophrenia

Beraki, S. (2008) · Figshare · Cited by 1

New Approaches to Treatment of Schizophrenia by Enhancing N-methyl- d -aspartate Neurotransmission

Tsai, G. E. (2007) · Progress in Neurotherapeutics and Neuropsychopharmacology · doi:10.1017/s1748232107000055 · Cited by 1

Kainic acid-induced seizures: inflammation and excitotoxic neuronal damage in the developing rat hippocampus

Järvelä, J. (2011) · UTUPub (University of Turku) · Cited by 1

Glutamatantagonisten in der Neurologie

Block, F., & Kosinski, C. (2001) · Der Nervenarzt · doi:10.1007/s001150050771 · Cited by 1

Schizophrenia, fats and lab rats

Bois, D., & Teresa, M. (2005) · Cited by 1

Antipsychotic Agents

Ablordeppey, S. Y., & Ofori, E. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc103.pub3 · Cited by 1

A spatial threshold for astrocyte calcium surgePreprint

Lines, J., Baraibar, A. M., Nanclares, C., Martín, E. D., Aguilar, J., Kofuji, P., Navarrete, M., & Araque, A. (2023) · eLife · doi:10.7554/elife.90046.1 · Cited by 1

Neural signatures of reduced serial dependence in anti-NMDAR encephalitis and schizophreniaPreprint

Stein, H., Barbosa, J., Lozano‐Soldevilla, D., Rosa-Justícia, M., Morató, A., Galan-Gadea, A., Prades, L., Muñoz-Lopetegui, A., Ariño, H., Martínez‐Hernández, E., et al. (2024) · doi:10.31234/osf.io/kz73s · Cited by 1

Enfermedades reumáticas y alergias, la dualidad del sistema inmunológico

Sánchez‐Zuno, G. A., Oregon‐Romero, E., Hernández‐Bello, J., González-Estévez, G., Vargas, R., & Muñóz-Valle, J. F. (2021) · Revista Alergia México · doi:10.29262/ram.v68i4.984

["PSD-95 Regulates Serotonin Receptor Function in vivo"]

Abbas, A. I. (2009) · OhioLink ETD Center (Ohio Library and Information Network)

Einfluss von Polymorphismen des DAO-Gens auf Schizophrenie und den Endophänotyp Gedächtnisleistung

Seebach, J. K. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16712

Neuropsychiatrische Funktion und Pathologie des NMDA-Rezeptors

Schiffelholz, T. (2004) · Steinkopff eBooks · doi:10.1007/978-3-7985-1957-2_26

Biomarkers and Surrogate Markers in Drug Development

Cutler, N. R., Sramek, J. J., Murphy, M. F., Riordan, H., Bieck, P. R., & Carta, A. (2010) · Wiley eBooks · doi:10.1002/9781444318579.ch4

Neuroprotection and Pain Management

Hassanzadeh, K., & Izadpanah, E. (2012) · InTech eBooks · doi:10.5772/30072

Mechanisms of synapse formation and maintenance: Insights from the developing and diseased nervous system

Hughes, E. G. (2009) · ScholarlyCommons (University of Pennsylvania)

Cognitive and negative symptoms in schizophrenia : studies of patients and healthy controls using magnetic resonance imaging

Rahm, C. (2013) · Figshare

Investigation of the Functional Effects of Two Novel Ampakines in the CNS

Jordan, G. R. (2007) · ERA

Behavioural and chemical changes induced by early brain development interruption from PCP : implications for schizophrenia

Bois, D., & Teresa, M. (2009)

Efectos de los antagonistas NMDA sobre la neurotransmisión serotonérgica y glutamatérgica en la corteza prefrontal. Mecanismo de acción de los fármacos antipsicóticos

Gil, J. L. (2009) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)

Experimental studies of N-methyl-D- aspartate receptor NR3 subunits

Öhman, A. (2008) · Figshare

Biological treatments for psychotic disorders

Girgis, R. R., Schobel, S., & Lieberman, J. A. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.027

Allocentric spatial navigation impairment in schizophrenic subject: A model-based study

Mohammadi, M., Mahdavi, A., Farashahi, S. G., & Bahrami, F. (2015) · Iranian Conference on Electrical Engineering · doi:10.1109/iraniancee.2015.7146195

Evaluation of novel dual-hit models of 'schizophrenia-like' symptoms in the rat

Gaskin, P. L. R. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)

EL USO DEL MODELO FARMACOLÓGICO BASADO EN LA ADMINISTRACIÓN EXPERIMENTAL DE MK-801, PARA LA REVISIÓN Y RE-DEFINICIÓN DEL SISTEMA LÍMBICO EN EL CONTEXTO DE LA ANÁTOMO-PATOLOGÍA

Bueno, A. M., & de Olmos, S. (2009) · Ciencias Psicológicas · doi:10.22235/cp.v3i1.140

High-throughput screening of glutaminase inhibitors for the pharmacotherapy of schizophrenia: Implementation of a fluorescence-based assay

Mihali, A., Macdonald, J., Tamir, H., & Rayport, S. (2020) · USC Research Bank (University of the Sunshine Coast) · doi:10.7916/cusj.v4i0.5594

P300-Amplitudenreduktion bei Patienten mit Schizophrenie und Gesunden in Abhängigkeit von einem Polymorphismus im NR3A-Gen

Prinz, S. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10537

Endoplasmic Reticulum Dynamic Structural Changes in Neurons: The Fission-Fusion Phenomena

Kucharz, K. (2010) · Lund University Publications (Lund University)

Synaptische Plastizität im Subikulum und ihre Veränderung im MK-801 Tiermodell der Psychose

Bartsch, J. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8926

Phencyclidine

Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50010-3

Inferring contextual field interactions from scalp EEG

Pflieger, M. E. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03390028

NMDA-receptor hypofunction versus excessive synaptic elimination as models of schizophrenia

Hoffman, R. E., & McGlashan, T. H. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03320023

Ab Initio studies of receptor interactions with AMPA ((S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid ) and Kainic acid (2S-(2α,3β,4β))-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid

Champeil, É., Proni, G., & Sapse, D. S. (2009) · Journal of Molecular Modeling · doi:10.1007/s00894-009-0460-y

Context, connection, and coordination: The need to switch

Oades, R. D., Röpcke, B., & Oknina, L. B. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03370025

What's new in … The neurochemistry of schizophrenia

Saich, R., Chapman, R., & Reynolds, G. P. (2004) · Medicine · doi:10.1383/medc.2004.32.7.xvii

Chance favors the prepared mind

Prins, R. C., Gladwin, M. T., Brod, L. S., Bhardwaj, A., & Hunter, A. J. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.1976

Spatial integration in perception and cognition: An empirical approach to the pathophysiology of schizophrenia

Chen, Y. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03260027

A wide-spectrum coordination model of schizophrenia

Barendregt, H. P. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03240024

Is sensory gating a form of cognitive coordination?

Kisley, M. A., & Davalos, D. B. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03340026

The N-methyl-D-aspartate receptor subunit NR3A: : Cloning, expression and interacting proteins

Eriksson, M. (2008) · Figshare

Detección de polimorfismos en el gen GRIN1 del receptor ionotrópico de glutamato activado por NMDA en una población de Bogotá

Ojeda, D. F., Lareo, L., AYALA, P., & Zarante, I. (2009) · DOAJ (DOAJ: Directory of Open Access Journals)

Levels of Ionotropic Glutamate and Muscarinic Receptors in Three Animal Models of Schizophrenia

Dean, B. (2011) · The Open Neuropsychopharmacology Journal · doi:10.2174/1876523801104010025

Cognitive coordination deficits: A necessary but not sufficient factor in the development of schizophrenia

Gooding, D. C., & Braun, J. G. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03290026

Reconciling schizophrenic deficits in top-down and bottom-up processes: Not yet

MacDonald, A. W. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03360029

The kynurenine pathway and development of schizophrenia : Immunological and genetic aspects

Holtze, M. (2011)

Gedächtnisdefizite nach Läsionen des medialen Temporallappens

Finke, C. (2013) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8387

Where the rubber meets the road: The importance of implementation

Barch, D. M., & Braver, T. S. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03230028

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Lindsley, C. W., Shipe, W. D., Wolkenberg, S. E., Theberge, C. R., Williams, D., Jr., Sur, C., & Kinney, G. G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777057599 · Cited by 156

The Hypothesis of NMDA Receptor Hypofunction for Schizophrenia

Chang, H.-J., Lane, H., & Tsai, G. E. (2012) · 臺灣精神醫學 · doi:10.29478/tjp.201209.0003

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

Jentsch, J. D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,329

Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies

Marino, M. J., & Conn, P. J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339544 · Cited by 134

N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Could Arise From Reduced Cortical Connectivity Rather Than Receptor Dysfunction

Hoffman, R. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180096017 · Cited by 3